Navigation Links
New molecule to treat brain disorders found

In a breakthrough that will spell good news for patients with Alzheimer's disease, Lou Gehrig's disease and other brain disorders, researchers say, Adenosine, a small molecule that plays important roles in controlling the heartbeat and normal sleep may also prove useful in treating these disorders of the brain and nervous system.

When tested on rat brain cells in the laboratory, the molecule, adenosine, mimicked the beneficial effects of naturally occurring chemicals known as nerve growth factors.

Nerve growth factors can prevent cell death in the brain, but, because of their size,// are difficult to administer to patients as a treatment. Larger size molecules are not able to cross the barrier that prevents many drugs from entering the brain.

Small molecules, on the other hand, can more easily enter the brain.Thus adenosine may be a potential treatment for brain ailments, according to investigators. In a new study, published in the online Proceedings of the National Academy of Sciences on March 6th, researchers report that adenosine did have a beneficial effect on the cultured brain cells.

While it is not clear if the molecule would have the same effect under more complex circumstances found in the body, researchers are hopeful that they can deliver adenosine to the brain, where it could protect cells from damage. One of study's authors, Dr. Moses V. Chao, of the New York University School of Medicine, said the strategy was a new one for fighting disease.

With this new step forward in the vastly unexplored and unclear frontier of the brain and the nervous system, many more cures and breakthroughs can be expected to follow.


Page: 1

Related medicine news :

1. Poisonous Parkinsons molecule discovered
2. Glenmark’s new molecule to go through trial
3. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
4. Ways to counter radiation effects with new molecule discovery
5. Same molecule found in meat, milk, tumors
6. Cell molecules behind neuro degenerative diseases
7. New anti-aging molecule could be coming up in way
8. So now here might come a memory molecule!!!
9. Lost molecule holds the key to lung cancer
10. THC molecule turns out to a boon for Alzheimer’s patient
11. Thyroid hormone treatment hastens recovery after cardiac surgery
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology: